20n

About:

A computational synthetic biology company.

Website: http://20n.com/

Twitter/X: tweet20n

Top Investors: Khosla Ventures, Y Combinator, Great Oaks Venture Capital, Signatures Capital, Eric Kwan

Description:

At 20n, They use algorithms to engineer microbes. Specifically, their algorithms engineer microbes to make chemicals. Like yeast produces alcohol during beer brewing, their engineered microbes will produce chemicals with therapeutic health and industrial biotech applications. The best illustration of this DARPA-backed technology is the bacteria They engineered to produce Paracetamol (also known as acetaminophen, and sold under the brand name Tylenol). Aside from this bacteria, there is no known natural way of producing acetaminophen. They are building data mining technology that will allow us to enable the bioproduction of a whole spectrum of valuable molecules. Below is the map of every chemical that can be made biologically, as discovered by 20n's algorithms.

Total Funding Amount:

$2.22M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)20n.com

Founders:

J.Christopher Anderson, Saurabh Srivastava

Number of Employees:

1-10

Last Funding Date:

2015-05-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai